ORPP logo
Image from Google Jackets

The Political Economy of Pharmaceutical Patents : US Sectional Interests and the African Group at the WTO.

By: Material type: TextTextSeries: Routledge Global Health SeriesPublisher: Oxford : Taylor & Francis Group, 2010Copyright date: ©2010Edition: 1st edDescription: 1 online resource (227 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781317020806
Subject(s): Genre/Form: Additional physical formats: Print version:: The Political Economy of Pharmaceutical PatentsDDC classification:
  • 382.456151
LOC classification:
  • HD9665.5 .M373 2016
Online resources:
Contents:
Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- List of Tables and Figures -- Acknowledgements -- List of Abbreviations -- Introduction -- 1 Explaining 'Who Gets What' in International Trade Decision-making -- 2 North/South Controversies in the TRIPS Negotiations: Between Hegemony and Domination? -- 3 Consensus Formation in the TRIPS Negotiations: agendas, agents and Turning Points -- 4 Legitimacy and the TRIPS Agreement: Globalised Law as 'Consent Without Consent' -- 5 The Post-TRIPS Context and the Intensification of a Contested Terrain: The Rise of the African Group1 (AG) at the WTO? -- Conclusion -- List of Interviewees -- References -- Index.
Summary: A fresh, multidisciplinary and exciting look at the making and remaking of pharmaceutical patents at the GAT/WTO, utilizing a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin addresses the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement, and consequently the role of the African Group at the WTO in the remaking of patent provisions.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- List of Tables and Figures -- Acknowledgements -- List of Abbreviations -- Introduction -- 1 Explaining 'Who Gets What' in International Trade Decision-making -- 2 North/South Controversies in the TRIPS Negotiations: Between Hegemony and Domination? -- 3 Consensus Formation in the TRIPS Negotiations: agendas, agents and Turning Points -- 4 Legitimacy and the TRIPS Agreement: Globalised Law as 'Consent Without Consent' -- 5 The Post-TRIPS Context and the Intensification of a Contested Terrain: The Rise of the African Group1 (AG) at the WTO? -- Conclusion -- List of Interviewees -- References -- Index.

A fresh, multidisciplinary and exciting look at the making and remaking of pharmaceutical patents at the GAT/WTO, utilizing a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin addresses the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement, and consequently the role of the African Group at the WTO in the remaking of patent provisions.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.